Analytical reference standards for laboratory research — not for human or veterinary use

Every batch, on the record.

The full archive of Certificates of Analysis for every batch ElevateBioLab has shipped. Each entry links to its source report with HPLC purity, mass identification, and test date for that lot.

All compounds are supplied strictly For Research Use Only (RUO) and are not for human or veterinary consumption.

Certificate of Analysis
99.44

Retatrutide 30mg

EB-1764133-P

Tested Jul 9, 2026View report
Certificate of Analysis
99.44

Retatrutide 20mg

EB-1764133-P

Tested Jul 9, 2026View report
Certificate of Analysis
99.44

Retatrutide 15mg

EB-1764133-P

Tested Jul 9, 2026View report
Certificate of Analysis
99.44

Retatrutide 10mg

EB-1764133-P

Tested Jul 9, 2026View report
Certificate of Analysis
99.44

Retatrutide 5mg

EB-1764133-P

Tested Jul 9, 2026View report
Certificate of Analysis
99.32

Tesamorelin 10mg

EB-4065773-P

Tested Jul 9, 2026View report
Certificate of Analysis
99.36

Wolverine Blend 20mg

EB-4339222-P

Tested Jul 9, 2026View report
Certificate of Analysis
99.34

TB-500 10mg

EB-8408241-P

Tested Jul 9, 2026View report
Certificate of Analysis
99.34

TB-500 5mg

EB-8408241-P

Tested Jul 9, 2026View report
Certificate of Analysis
99.42

BPC-157 10mg

EB-9628420-P

Tested Jul 9, 2026View report
Certificate of Analysis
99.42

BPC-157 5mg

EB-9628420-P

Tested Jul 9, 2026View report
Certificate of Analysis
>=99%

Melanotan-2 10mg

LOT-EBL-MT2-10-2026A

Tested Jan 15, 2026View report
Certificate of Analysis
>=99%

L-Carnitine 1200mg

LOT-EBL-LCAR-1200-2026A

Tested Jan 15, 2026View report
Certificate of Analysis
>=99%

Glutathione 1500mg

LOT-EBL-GLUT-1500-2026A

Tested Jan 15, 2026View report
Certificate of Analysis
>=98%

Tesamorelin/Ipamorelin/CJC-1295 Blend 12mg

LOT-EBL-TIC-12-2026A

Tested Jan 15, 2026View report
Certificate of Analysis
>=98%

Tesamorelin/Ipamorelin Blend 10mg

LOT-EBL-TI-10-2026A

Tested Jan 15, 2026View report
Certificate of Analysis
>=99%

Sermorelin 5mg

LOT-EBL-SERM-5-2026A

Tested Jan 15, 2026View report
Certificate of Analysis
>=98%

MOTS-c 40mg

LOT-EBL-MOTSC-40-2026A

Tested Jan 15, 2026View report
Certificate of Analysis
>=98%

MOTS-c 20mg

LOT-EBL-MOTSC-20-2026A

Tested Jan 15, 2026View report
Certificate of Analysis
>=98%

Selank 10mg

LOT-EBL-SELANK-10-2026A

Tested Jan 15, 2026View report
Certificate of Analysis
>=98%

Semax 10mg

LOT-EBL-SEMAX-10-2026A

Tested Jan 15, 2026View report
Certificate of Analysis
>=99%

CJC-1295 no-DAC 10mg

LOT-EBL-CJC-10-2026A

Tested Jan 15, 2026View report
Certificate of Analysis
>=99%

Ipamorelin 10mg

LOT-EBL-IPAM-10-2026A

Tested Jan 15, 2026View report
Certificate of Analysis
>=99%

Ipamorelin 5mg

LOT-EBL-IPAM-5-2026A

Tested Jan 15, 2026View report
Certificate of Analysis
>=99%

Ipamorelin 2mg

LOT-EBL-IPAM-2-2026A

Tested Jan 15, 2026View report
Certificate of Analysis
>=98%

GLOW Blend 70mg

LOT-EBL-GLOW-70-2026A

Tested Jan 15, 2026View report
Certificate of Analysis
>=98%

KLOW Blend 80mg

LOT-EBL-KLOW-80-2026A

Tested Jan 15, 2026View report
Certificate of Analysis
>=99%

NAD+ 1000mg

LOT-EBL-NAD-1000-2026A

Tested Jan 15, 2026View report
Certificate of Analysis
>=99%

NAD+ 500mg

LOT-EBL-NAD-500-2026A

Tested Jan 15, 2026View report
Certificate of Analysis
>=99%

NAD+ 300mg

LOT-EBL-NAD-300-2026A

Tested Jan 15, 2026View report
Certificate of Analysis
>=99%

GHK-Cu 100mg

LOT-EBL-GHKCU-100-2026A

Tested Jan 15, 2026View report
Certificate of Analysis
>=99%

GHK-Cu 50mg

LOT-EBL-GHKCU-50-2026A

Tested Jan 15, 2026View report
Certificate of Analysis
>=99%

Tirzepatide 30mg

LOT-EBL-TIRZ-30-2026A

Tested Jan 15, 2026View report
Certificate of Analysis
>=99%

Tirzepatide 20mg

LOT-EBL-TIRZ-20-2026A

Tested Jan 15, 2026View report
Certificate of Analysis
>=99%

Tirzepatide 10mg

LOT-EBL-TIRZ-10-2026A

Tested Jan 15, 2026View report
Certificate of Analysis
>=99%

Semaglutide 10mg

LOT-EBL-SEMA-10-2026A

Tested Jan 15, 2026View report
Certificate of Analysis
>=99%

Semaglutide 5mg

LOT-EBL-SEMA-5-2026A

Tested Jan 15, 2026View report